Enthea

Mental health support for employees should be a no-brainer. But sadly, it's still a topic of debate. Do you know how much mental illness costs the US each year? A whopping $3.7 trillion. That's more than diabetes or even heart disease. Investing in mental health & providing a safe, supportive work environment for your employees is not only the right thing to do, but it also helps your business succeed. When employers support mental health…. -Employees are happier & stay longer. -Employees become more productive & do their best work. -Employees feel cared for & valued. -Employees engage more & tend to be more satisfied with their jobs. Which simply means more success and revenue for any business. Let us help you take care of your employees by providing the services and experts that will help them feel their best to do their best!

Are we just treating symptoms instead of getting to the root cause? 💊 In our latest episode of the Health & Wealth Power Hour, Sherry Rais, CEO of Enthea, sheds light on the common pitfalls of conventional mental health treatments—where medications often stack up, addressing symptoms but not the real issues. But what if there’s a way to break free from this cycle? Enter psychedelic therapy, a revolutionary approach that goes beyond the surface to reset the brain, foster new connections, and tackle the root causes of trauma and #mentalhealth struggles. Listen to this powerful excerpt where Sherry explains how psychedelic therapy is changing the game. And don't forget to check out the full episode tomorrow with the link in the comments!

Now is the time for women and survivors of trauma to demonstrate support for breakthrough healing treatments that will help 13 million Americans living with PTSD.  Read my TIME article and please share widely 🙏 This Friday the @FDA will make a decision that can either enable or block access to MDMA Assisted Therapy that could help so many, especially veterans and women survivors of sexual violence. Every 68 seconds an American is sexually assaulted. 91% of victims are women. This silent violence is perpetuated by social stigma and shame. Until today, women have been mostly silent when we are the largest population in urgent and desperate need of access to this therapy. But it is time for a movement to demand access to healing now. Join me in calling on the FDA to approve MDMA Assisted Therapy now!  https://lnkd.in/gucaC9hV #MDMA4PTSD #FDA #ApproveMDMATherapy @FDA @ProteaFoundation

🧠🌟 Google Co-Founder Sergey Brin Pledges $15M To Psychedelics Research Start-Up 🌿🔬 Google co-founder Sergey Brin is making headlines with a $15 million investment in Soneira, a startup focused on ibogaine research. The initiative is part of Brin's non-profit investment fund, Catalyst4, which he launched in 2021 to support groundbreaking innovations. This move highlights growing interest from Silicon Valley in the therapeutic potential of psychedelics for mental health solutions. 🔗 Read more: https://lnkd.in/gvGxxJzW #SergeyBrin #Soneira #Catalyst4 #MentalHealth #Ibogaine #Iboga #Psychedelics #PsychedelicRenaissance

This is Your Brain on Magic Mushrooms! 🍄🧠 A new #Nature study led by Josh Siegel shows that high doses of psilocybin cause widespread changes in brain function, desynchronizing brain activity and altering our sense of self, time, and space. This desynchronization may drive brain plasticity triggered by psych€-delics. 🍄 Researchers tracked healthy adults before, during, and weeks after a psilocybin dose. They found profound desynchronization across the cerebral cortex and subcortex, especially in the default mode network (DMN), crucial for our sense of self. 🧠 Psilocybin’s disruptive effects decreased when participants focused on simple tasks, suggesting a basis for grounding during psychedelic therapy. 🍄 The study also showed a lasting decrease in connectivity between the anterior hippocampus and DMN circuits, controlling self-oriented thinking and memory. This shift might change how someone perceives their place and story in the world, potentially explaining psilocybin’s antidepressant effects. This study is likely the most advanced and extensive study on the brain effects of psych€-delics ever conducted, involving roughly 18 magnetic imaging visits per participant. Psychedelic science is moving fast, very curious for what will come next. https://lnkd.in/dgX-VhJB #mentalhealth #psychiatry #neuroscience #pharmacology

TO MY COMMUNITY: PLEASE SIGN THIS PETITION TO SUPPORT MDMA-ASSISTED THERAPY FOR PTSD The FDA is on the verge of making a critical decision regarding the approval of MDMA-assisted therapy for PTSD. Unfortunately, a recent recommendation from the FDA Advisory Committee opposed this approval, despite the significant potential benefits for millions living with PTSD. Clinical trials have demonstrated remarkable results, with 71% of participants no longer meeting the diagnostic criteria for PTSD after MDMA-assisted therapy. This therapy could offer a transformative solution for those struggling with this challenging condition. The FDA's final decision is due in August 2024. Your support is vital to help make this life-changing treatment available. By signing the petition, you can make a real difference. Every day without this treatment, we risk losing more lives to the devastating impact of PTSD. The time to act is NOW. And it takes two minutes! Sign the petition here: https://lnkd.in/eWqzmpHT Thank you for your support!

Huge announcement: Fluence and Enthea are joining forces to expand access to reimburse ketamine-assisted therapy and top-notch training for clinicians! This means: - More people can access effective mental health treatment with ketamine. - Therapists can get the training they need to provide safe, high-quality care. - Employers can offer their employees a valuable mental health benefit. This is a major step forward for the field and I'm really grateful to everyone who made it happen! Read the full press release here: https://lnkd.in/gHxmGB2f

Thrilled to announce Enthea's new partnerships with CannaCoverage Insurance Services and F.E.M. to broaden access to Ketamine-Assisted Therapy benefit plans! This collaboration aims to revolutionize mental health care by covering treatments that address the root causes of depression, anxiety, and PTSD, rather than just managing symptoms. Together, we are dedicated to educating employers and their teams about these transformative health benefits now available to all group health plans. With the extensive network and expertise of CannaCoverage and F.E.M., we're setting a new standard for mental health care that focuses on effective, evidence-based solutions. Read the full press release here: https://lnkd.in/eSsHvEeT

Psychedelic Saiyan ❌ Psychedelic HR ✔ The burnout rate among employees is staggering- 78% according to the UKG Workforce Institute! And it's not just burnout; productivity is plummeting too, and resignation is increasing during this ongoing war for talent. What does HR have for the mental well-being of their team? Traditional treatments are effective but tend to lose their potency over time. What then? Maybe psychedelic therapy, the talk around the town (or continent afar). Ketamine Assisted Therapy (KAT) is being introduced as an ancillary benefit for employees. What’s the scoop on KAT?  It works wonders for treatment-resistant depression, Anxiety disorders, and PTSD So, who let the KAT out? I heard about KAT while listening to a podcast, People Managing People, by Enthea co-founder Sherry Rais Enthea, a US-based startup, is pioneering KAT. They're partnering with corporations to include KAT in employee benefit schemes. And the results? Out of 320 employees at a partnered organization, about 7% accessed the therapy: 🔥 An 86% improvement in PTSD 🔥 A 67% reduction in major depressive disorder symptoms 🔥 A 65% decline in generalized anxiety disorder symptoms Peter Thiel has invested in Atai Life Sciences, which is working towards producing some of the aforementioned drugs. HRs tried hard to manage the great resignation. Now they can look into great regeneration. Photograph sourced from The Economic Times #Humanresource #HR #mentalhealth #wellbeing #Therapy #notlawyering #Lawandmanagement #Employee #startup

Hot in benefits: Ketamine-Assisted Therapy Originating in the 1960s as an anesthetic, ketamine has pivoted to the mental health scene due to its rapid antidepressant effects. Fast forward to today, ketamine-assisted therapy (KAT) emerges as a beacon of hope for those struggling with treatment-resistant conditions, offering swift relief and a new lease on life. But how did this once-controversial substance gain traction in mainstream psychotherapy? And what could this mean for your benefits package? Discover how leading employers are harnessing KAT to enhance employee wellness. Join us for an in-depth exploration of this game-changing therapy on our latest blog—click the link to read more and see how you can integrate innovative solutions like KAT into your offerings!